Compare STIM & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STIM | HYPR |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4M | 101.3M |
| IPO Year | 2018 | 2021 |
| Metric | STIM | HYPR |
|---|---|---|
| Price | $2.88 | $0.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $3.00 | $1.59 |
| AVG Volume (30 Days) | ★ 2.7M | 499.8K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.25 | 23.21 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,776,000.00 | $13,563,000.00 |
| Revenue This Year | $11.10 | $50.75 |
| Revenue Next Year | $11.92 | $29.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.22 |
| 52 Week Low | $0.80 | $0.79 |
| 52 Week High | $3.71 | $2.22 |
| Indicator | STIM | HYPR |
|---|---|---|
| Relative Strength Index (RSI) | 56.78 | 33.95 |
| Support Level | $1.21 | N/A |
| Resistance Level | N/A | $1.19 |
| Average True Range (ATR) | 0.16 | 0.04 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 33.05 | 22.90 |
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.